Skip to main content

Table 1 Studies assessing efficacy of bilateral prophylactic mastectomy (PM) in BRCA1 and BRCA2 carriers

From: Invasive breast cancer following bilateral subcutaneous mastectomy in a BRCA2 mutation carrier: a case report and review of the literature

 

Hartmann et al [3]

Meijers-Heijboer et al [4]

Rebbeck et al [5]

Study recruitment centers

USA

Netherlands

USA, Canada, UK, Netherlands

Median follow-up (yrs)

13.4

2.8

5.5

Mean age at surgery (yrs)

39

36

38

Number of PM patients

18

76

105

Number of controls

-

63

378

Type of study

Retrospective cohort

Prospective cohort

Case-control

Primary invasive breast cancer

   

- in cases (after PM)

0

0

1 (BRCA1 carrier)

- in controls

-

8 (13%)

184 (49%)